Cancer News and Research

Latest Cancer News and Research

New DNA tool can predict people's height and potentially assess risk for serious illnesses

A new DNA tool created by Michigan State University can accurately predict people's height, and more importantly, could potentially assess their risk for serious illnesses, such as heart disease and cancer.

5 Oct 2018

Researchers identify sex-specific genetic risk factor for pancreatic cancer

In a new study from Lawson Health Research Institute and Western University's Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females.

5 Oct 2018

A new initiative to detect and prevent cancer in Southwest Virginia

A new University of Virginia Cancer Center initiative will empower Southwest Virginia residents to lead projects to better detect and prevent cancer in the region.

5 Oct 2018

Study shows adherence to annual lung cancer screening is not optimal

A study from the Thoracic Oncology Research Group (TORG), Division of Pulmonary and Critical Care, Medical University of South Carolina, aimed to examine the adherence to annual low-dose computed tomography (LDCT) screening after baseline LDCT within the Veteran Health Administration Lung Cancer Screening Demonstration Project (LCDSDP).

5 Oct 2018

Krembil scientists develop potential treatment to stop knee and spine osteoarthritis

Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks.

5 Oct 2018

Study reveals factors linked to the development of Crohn's disease

How cells talk to each other, and what they say, has long held fascination for Seema Khurana, professor of biology and biochemistry.

5 Oct 2018

Tarragon and bitter melon supplements may be less helpful for women than men

Russian tarragon and bitter melon supplements may be less helpful for women than men when it comes to combating metabolic syndrome, whose symptoms include high blood sugar, high blood pressure and excess fat around the waist.

5 Oct 2018

Study: Chemotherapy drugs may promote muscle mitochondrial dysfunction

Chemotherapy drugs to treat breast cancer may promote muscle mitochondrial dysfunction, according to new research. Dysfunctional mitochondria, the energy centers of the cells, may contribute to fatigue and weakness that some people with breast cancer experience through the course of disease treatment.

5 Oct 2018

Low-dose aspirin use associated with reduced ovarian cancer risk

Taking a low-dose aspirin daily may help women lower their risk of developing ovarian cancer. A new study co-led by Moffitt Cancer Center found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users.

4 Oct 2018

New report provides overview of cancer risk among U.S. Hispanics/Latinos

The cancer burden in Puerto Rico, a U.S. territory with a 99% Hispanic population, is substantially different from that of Hispanics in the continental U.S., according to Cancer Statistics for Hispanics/Latinos, 2018.

4 Oct 2018

Podcast: KHN’s ‘What the Health?’ Some things old, some things new

Congress passed major health-related legislation in time for the fiscal year, which began Monday, including a broad bill to address the opioid epidemic and a spending bill for the Department of Health and Human Services.

4 Oct 2018

Sunscreen chemicals in seawater could pose risk to human health, finds study

A study by Hong Kong Baptist University has detected an extensive amount of sunscreen chemicals in seawater that could pose a risk to human health.

4 Oct 2018

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.

4 Oct 2018

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.

4 Oct 2018